Analytical method validation and transfer are critical steps to ensure that the analytical procedures or methods developed can accurately and reliably analyze samples, consistently produce accurate results, and comply with current good manufacturing practices (cGMP). As one of the global leaders in protein and peptide formulation science and manufacturing, CD Formulation's protein characterization team provides reliable validation and transfer services for a variety of protein and peptide therapeutic products, such as monoclonal antibodies (mAbs), fusion proteins, bispecific antibodies, antibody-drug conjugates (ADCs), etc., following current USP/EP/ICH guidance, thereby reducing the cost, complexity, and overall timeline of drug development.
Analytical method validation and transfer, a necessary test method, is a key step in selecting and optimizing methods for testing raw materials, intermediate materials, final containers, and excipients, ensuring that data complies with current good manufacturing practices (cGMP).
Fig. 1 Analytical method transfer. (CD Formulation)
Due to their special properties, biological products such as proteins and peptides require specific scientific expertise and regulatory knowledge. CD Formulation follows the current USP/EP/ICH guidance to provide a standardized analytical method validation process that complies with cGMP for your protein/peptide biopharmaceuticals and biosimilars to ensure that your biological products meet regulatory requirements and enter the clinical research stage smoothly.
We provide validation support for any analytical method that may be involved in the development and manufacturing of therapeutic protein and peptide biologics and biosimilars. For protein/peptide finished products, the following indicators are focused on.
According to ICH guidance, our validation content focuses include:
The formal transfer of analytical methods is an essential cGMP process for all protein/peptide biologics development. CD Formulation follows the current USP/EP/ICH guidance to provide analytical method transfer services based on cGMP to ensure the correctness and reliability of analytical methods.
Our analytical method transfer services support the transfer of your methods or technologies to our analytical laboratories for ongoing research or the transfer of our developed and/or validated analytical methods to one or more laboratories designated by you, taking into account any restrictions, to ensure the smooth progress of your project.
Published Data
Technology: High-Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS/MS)
Journal: Heliyon.
IF: 3.776
Published: 2024
Results:
The authors developed a HPLC-MS/MS method for the determination of the concentration and stability of the antihypertensive peptide FR-6 in rat plasma. Plasma samples were pretreated by methanol precipitation of proteins. 0.1% formic acid (0.1% (A) and formic acid (0.125%) in methanol-ammonium carbonate (2 mM) (B) were used as mobile phases. Isotope-labeled peptides (sequence unchanged) were used as internal standards (IS) for validation. The results showed that the method exhibited good linearity for FR-6 concentrations, and the inter- and intra-day precisions were 0.61–6.85% and 1.76–11.75%, respectively, and the inter- and intra-day accuracies were -7.28–0.13% and -7.20–2.28%, respectively, making it a reliable method for the determination of the antihypertensive peptide FR-6 concentration.
Fig. 2 A sensitive and specific LC-MS/MS method for determination of a novel antihypertensive peptide FR-6 in rat plasma and pharmacokinetic study. (Yang Y, et al., 2024)
Analytical method validation and transfer is one of the essential key factors for the successful development of protein/peptide biologics. CD Formulation is committed to providing integrated validation and transfer services to support the smooth implementation of your project. Please feel free to contact us if you are interested in our services or have further questions. We look forward to working with you to promote development and innovation in the biopharmaceutical field.
References